JNJ sprawa mezotelioma odwrócono odszkodowania karne

What happened: In a significant legal development, a Georgia jury ordered Bayer to pay $2.1 billion to a single plaintiff in March 2025, including $2 billion in punitive damages, over its Roundup weed killer. Meanwhile, a California jury's $950 million punitive damages award against Johnson & Johnson (JNJ) for a mesothelioma case was overturned, but a $16 million compensatory damages verdict stood. Separately, a federal jury found Live Nation, owner of Ticketmaster, guilty of operating as a monopoly and overcharging fans.

Market impact: The Bayer verdict sent shockwaves through the pesticide industry and the MAHA (Make Agriculture Healthy Again) movement, potentially leading to increased regulatory scrutiny and higher product liability costs. The JNJ decision could impact the pharmaceutical industry's liability for talc-related lawsuits. Live Nation's verdict may lead to changes in the music industry's ticketing practices and increased regulatory oversight.

What to watch next: Investors should monitor Bayer's Q2 earnings (May 6) for any impact on guidance due to the Roundup verdict. For JNJ, watch for further legal developments in talc-related cases and the company's Q2 earnings (April 19). In the music industry, track regulatory responses to Live Nation's verdict and any changes in ticketing practices.